The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal ...

Corcept sought FDA approval despite finding relacorilant was statistically no better than placebo in one of two Phase III ...

Analysts are intrested in these 5 stocks: ( ($DBRG) ), ( ($TKO) ), ( ($GFS) ), ( ($CORT) ) and ( ($AAPL) ). Here is a breakdown of their recent ...

Thank you to everyone who entered our 11th Annual Holiday Tech Giveaway! The response this year has been incredible, and we’re grateful for your continued support of Android Headlines. Winner ...